Meyd-773 //free\\

Three TNBC PDXs (BRCA1‑mutated, PTEN‑null, PI3K‑wild‑type) were implanted subcutaneously into NOD/SCID mice (n = 8/group). Dosing regimens mirrored the orthotopic study. Survival was defined as time to tumor volume ≥ 1500 mm³.

If you're ready, I can start by providing a general template, and we can work from there: MEYD-773